← Back to Search

Family Education for Psychosis

N/A
Recruiting
Led By Adam Abba-Aji, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Young adult service user is aged 17-27 at time of recruitment
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-24 months post-intervention
Awards & highlights

Study Summary

This trial will provide a psychoeducation intervention to equip families of young adults with psychosis with knowledge and skills to reduce burden and foster community stability.

Who is the study for?
This trial is for family carers of young adults aged 17-27 with psychosis in Edmonton who have been admitted to or discharged from specific psychiatric units within the last year. It's not suitable for those not proficient in English or if the young adult hasn't had recent unit admission/discharge.Check my eligibility
What is being tested?
The study tests a psychoeducation program aimed at teaching family carers how to support young adults with psychosis. The intervention includes nine expert-reviewed modules delivered over nine weeks, focusing on skill and knowledge enhancement.See study design
What are the potential side effects?
Since this intervention involves educational sessions rather than medical treatments, traditional side effects are not expected. However, participants may experience emotional discomfort or stress during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 17 and 27 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-24 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-24 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Family Burden Interview Schedule
Manchester Short Assessment of Quality of Life
Positive and Negative Symptom Schedule
Secondary outcome measures
Community Appointment Frequency
Crisis Service Frequency
Emergency Department Visit Frequency
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Family Psychoeducation Intervention ArmExperimental Treatment1 Intervention
These participants will receive the psychoeducation intervention and outcome measures will be taken from them and their young adult service user. The intervention includes psychoeducation on stages of a family's journey, the biopsychosocial basis of psychosis, and skills for coping (Acceptance and Commitment Therapy for Caregivers) and communicating (LEAP).

Find a Location

Who is running the clinical trial?

Alberta Health servicesOTHER
158 Previous Clinical Trials
649,566 Total Patients Enrolled
University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,034 Total Patients Enrolled
Families Supporting Adults with Mental Illness-AlbertaUNKNOWN

Media Library

Supporting Patients by Family Education in Psychotic Illness Group Clinical Trial Eligibility Overview. Trial Name: NCT05500001 — N/A
Psychosis Research Study Groups: Family Psychoeducation Intervention Arm
Psychosis Clinical Trial 2023: Supporting Patients by Family Education in Psychotic Illness Group Highlights & Side Effects. Trial Name: NCT05500001 — N/A
Supporting Patients by Family Education in Psychotic Illness Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05500001 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What restrictions are in place for individuals wishing to enroll in this clinical experiment?

"One hundred individuals aged 17 to 27 that display signs of paranoia are needed for this study. All participants must have recently been admitted or discharged from a psychiatric unit run by either Alberta Health Services or Covenant Health located in the Edmonton Zone within the past year."

Answered by AI

Does the trial have an age restriction, and if so what is it?

"In accordance with the trial's inclusion criteria, candidates must be between 17 and 27 years old."

Answered by AI

How many participants are being included in the current experiment?

"Affirmative. Per the information available on clinicaltrials.gov, this medical investigation is actively seeking patients to partake in their study. Initially posted on September 1st 2022, the research necessitates 100 participants from 4 distinct locations."

Answered by AI

Is recruitment currently open for this research investigation?

"The public record on clinicaltrials.gov reveals that this investigation is actively looking for participants, which was initially posted in early September of 2022 and has had a recent update made at the start of October."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Recent research and studies
clinicaltrials.govStudy
Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
2022. "Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05500001.
~44 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top